
08/20/2025
https://bit.ly/45UTcvJ
🚨 Attention Zepbound Users! 🚨
Starting July 1, 2025, CVS Caremark will drop coverage for Zepbound (tirzepatide) and switch to Wegovy (semaglutide) as the preferred weight-loss medication.
⚠️ Why this matters:
✨ Zepbound has shown greater results in weight loss than Wegovy
✨ Patients mid-treatment may face setbacks if forced to switch
✨ Exceptions may be possible—talk to your provider today
At Kinetix Medical Weight Loss And Wellness, we’re here to help you navigate these changes, fight for your treatment, and find the best solution for YOU. 💙
📞 Call us: 773-270-8223
🔗 Learn more: kinetixweightloss.com